• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强啡肽B与脊髓镇痛:大麻素CP55,940、Δ⁹-四氢大麻酚和花生四烯酸乙醇胺诱导的抗伤害感受

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.

作者信息

Houser S J, Eads M, Embrey J P, Welch S P

机构信息

Department of Nurse Anesthesia, Virginia Commonwealth University, Richmond, VA 23298-0613, USA.

出版信息

Brain Res. 2000 Feb 28;857(1-2):337-42. doi: 10.1016/s0006-8993(00)01981-8.

DOI:10.1016/s0006-8993(00)01981-8
PMID:10700588
Abstract

The endogenous opioid dynorphin B was evaluated for its role in cannabinoid-induced antinociception. Previous work in our laboratory has shown that the synthetic, bicyclic cannabinoid, CP55,940, induces the release of dynorphin B whilst the naturally occurring cannabinoid, Delta(9)-tetrahydrocannabinol (Delta(9)-THC), releases dynorphin A. The dynorphins contribute in part to the antinociceptive effects of both cannabinoids at the level of the spinal cord. The present study compares dynorphin B released from perfused rat spinal cord in response to acute administration of anandamide (AEA), Delta(9)-THC and CP55,940 at two time points, 10 min and 30 min post administration, and attempts to correlate such release with antinociceptive effects of the drugs. Dynorphin B was collected from spinal perfusates of rats pretreated with Delta(9)-THC, CP55,940 or AEA. The supernatant was lyophilized and the concentrations of dynorphin B were measured via radioimmunoassay. At a peak time of antinociception (10 min), CP55,940 and Delta(9)-THC induced significant two-fold increases in the release of dynorphin B. AEA did not significantly release dynorphin B. Upon a 30-min pretreatment with the drugs, no significant dynorphin B release was observed, although antinociceptive effects persisted for CP55,940 and Delta(9)-THC. Previous work indicates that Delta(9)-THC releases dynorphin A while AEA releases no dynorphin A. This study confirms that although all three test drugs produced significant antinociception at 10 min, the endocannabinoid, AEA, does not induce antinociception via dynorphin release. Thus, our data indicate a distinct mechanism which underlies AEA-induced antinociception.

摘要

对内源性阿片肽强啡肽B在大麻素诱导的镇痛作用中的作用进行了评估。我们实验室之前的研究表明,合成的双环大麻素CP55,940可诱导强啡肽B的释放,而天然存在的大麻素Δ⁹-四氢大麻酚(Δ⁹-THC)则释放强啡肽A。强啡肽在脊髓水平上部分促成了两种大麻素的镇痛作用。本研究比较了在给药后10分钟和30分钟这两个时间点,灌注大鼠脊髓释放的强啡肽B对急性给予花生四烯乙醇胺(AEA)、Δ⁹-THC和CP55,940的反应,并试图将这种释放与药物的镇痛作用相关联。从用Δ⁹-THC、CP55,940或AEA预处理的大鼠脊髓灌流液中收集强啡肽B。将上清液冻干,并通过放射免疫测定法测量强啡肽B的浓度。在镇痛作用的峰值时间(10分钟),CP55,940和Δ⁹-THC诱导强啡肽B的释放显著增加了两倍。AEA没有显著释放强啡肽B。在用这些药物进行30分钟预处理后,虽然CP55,940和Δ⁹-THC的镇痛作用仍然存在,但未观察到强啡肽B的显著释放。先前的研究表明,Δ⁹-THC释放强啡肽A,而AEA不释放强啡肽A。本研究证实,尽管所有三种受试药物在10分钟时均产生了显著的镇痛作用,但内源性大麻素AEA并非通过强啡肽释放诱导镇痛。因此,我们的数据表明了AEA诱导镇痛的独特机制。

相似文献

1
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.强啡肽B与脊髓镇痛:大麻素CP55,940、Δ⁹-四氢大麻酚和花生四烯酸乙醇胺诱导的抗伤害感受
Brain Res. 2000 Feb 28;857(1-2):337-42. doi: 10.1016/s0006-8993(00)01981-8.
2
Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.强啡肽B参与大麻素CP55,940在脊髓中的抗伤害感受作用。
J Pharmacol Exp Ther. 1997 May;281(2):730-7.
3
Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.鞘内注射给予小鼠后,花生四烯乙醇胺和氟花生四烯乙醇胺诱导的抗伤害感受及对Δ⁹-四氢大麻酚的交叉耐受性的特征:对Δ⁹-四氢大麻酚诱导的抗伤害感受的阻断
J Pharmacol Exp Ther. 1995 Jun;273(3):1235-44.
4
Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.大麻素对强啡肽A的调节作用:与大麻素诱导的抗伤害感受的相关性
Eur J Pharmacol. 1999 Aug 13;378(3):237-48. doi: 10.1016/s0014-2999(99)00479-3.
5
Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.花生四烯乙醇胺诱导的耐受性特征:与δ9-四氢大麻酚诱导的与强啡肽能系统相互作用的比较。
Drug Alcohol Depend. 1997 Apr 14;45(1-2):39-45. doi: 10.1016/s0376-8716(97)01342-2.
6
Synergistic interactions of endogenous opioids and cannabinoid systems.内源性阿片类物质与大麻素系统的协同相互作用。
Brain Res. 1999 Nov 27;848(1-2):183-90. doi: 10.1016/s0006-8993(99)01908-3.
7
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.SR141716A对中枢给予大麻素的抗伤害感受作用的差异性阻断。
J Pharmacol Exp Ther. 1998 Sep;286(3):1301-8.
8
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.非关节炎和关节炎大鼠中Δ9-四氢大麻酚和花生四烯乙醇胺抗伤害感受的特征
Pharmacol Biochem Behav. 1998 May;60(1):183-91. doi: 10.1016/s0091-3057(97)00583-2.
9
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.1 型大麻素受体配体在纹状体中间棘突投射神经元的细胞培养模型中表现出功能选择性。
J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025. Epub 2014 Jul 18.
10
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.大鼠脑大麻素结合位点在急性或慢性暴露于其内源性激动剂花生四烯乙醇胺或Δ⁹-四氢大麻酚后的变化。
Pharmacol Biochem Behav. 1995 Aug;51(4):731-7. doi: 10.1016/0091-3057(95)00023-p.

引用本文的文献

1
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years.过去25年中CB1R和CB2R配体在睡眠障碍和成瘾行为中的作用
Pharmaceuticals (Basel). 2025 Feb 18;18(2):266. doi: 10.3390/ph18020266.
2
The Development of Cannabinoids as Therapeutic Agents in the United States.大麻素类药物在美国作为治疗药物的发展。
Pharmacol Rev. 2024 Aug 15;76(5):915-955. doi: 10.1124/pharmrev.123.001121.
3
Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System.
中枢神经系统中的神经炎症:探索内源性大麻素系统不断演变的影响。
Biomedicines. 2023 Sep 26;11(10):2642. doi: 10.3390/biomedicines11102642.
4
Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice.大麻素 1 型受体和μ 阿片受体激动剂协同抑制小鼠腹痛且无副作用。
J Neurosci. 2022 Aug 17;42(33):6313-6324. doi: 10.1523/JNEUROSCI.0641-22.2022. Epub 2022 Jul 5.
5
Receptor mechanisms underlying the CNS effects of cannabinoids: CB receptor and beyond.大麻素对中枢神经系统作用的受体机制:CB 受体及其他。
Adv Pharmacol. 2022;93:275-333. doi: 10.1016/bs.apha.2021.10.006. Epub 2021 Dec 13.
6
Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase.长期食用美味食物后戒断对疼痛敏感性的调节:脂肪酸酰胺水解酶的新作用
Front Pharmacol. 2020 Mar 16;11:266. doi: 10.3389/fphar.2020.00266. eCollection 2020.
7
Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley rats.κ 阿片受体拮抗剂可减弱成年雄性 Sprague-Dawley 大鼠 THC 诱导的厌恶反应。
Pharmacol Biochem Behav. 2017 Dec;163:30-35. doi: 10.1016/j.pbb.2017.10.010. Epub 2017 Oct 31.
8
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.大麻素类药物的阿片类药物节约效应:系统评价和荟萃分析。
Neuropsychopharmacology. 2017 Aug;42(9):1752-1765. doi: 10.1038/npp.2017.51. Epub 2017 Mar 22.
9
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia.在炎症性机械性痛觉过敏模型中,大麻素受体激动剂与阿片受体激动剂之间的外周相互作用。
Brain Res Bull. 2016 Jul;125:211-7. doi: 10.1016/j.brainresbull.2016.07.009. Epub 2016 Jul 20.
10
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.大麻素强化作用的临床前研究。向史蒂夫·戈德堡博士的科研致敬。
Psychopharmacology (Berl). 2016 May;233(10):1845-66. doi: 10.1007/s00213-016-4244-7. Epub 2016 Mar 30.